TY - JOUR
T1 - Cancer prevention health services research
T2 - An emerging field
AU - Zhao, Hui
AU - Tektiridis, Jennifer H.
AU - Zhang, Ning
AU - Chamberlain, Robert M.
N1 - Funding Information:
We identified four funding agencies that have invested research funds in the CP-HSR area: the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality, National Institutes of Health, and Centers for Disease Control and Prevention, the American Cancer Society, and the Cancer Prevention and Research Institute of Texas (CPRIT). For fiscal years 2009 and 2010, US $84 million in funding was earmarked from the Federal Recovery Fund for 25 R18 and 36 R01 grants to promote HSR. The American Recovery and Reinvestment Act of 2009 funded a total of 18 grant mechanisms for the National Institutes of Health (including the National Cancer Institute), of which seven focused on CP-HSR; in addition, one American Cancer Society grant focused on CP-HSR, and one National Cancer Institute grant for cancer prevention centers targeted studies to promote, evaluate, and improve cancer screening for lung, colorectal, or cervical cancer in 2010 (Table ). The Centers for Disease Control and Prevention supports disease prevention and HSR through a number of mechanisms, including its Preventative Services and Health Services block grants [] and programs from its Division of Cancer Prevention and Control. For all of these agencies, defining CP-HSR as a field and establishing its goals would help sharpen the focus of grant proposals on studies of effectiveness, efficiency, and access to preventive services.
Funding Information:
A relatively new and important source of funding is the Cancer Prevention grant program sponsored by the Cancer Prevention and Research Institute of Texas []. This program provides funding for unique projects and new partnerships aimed at increasing screening and vaccination rates with a preference for those employing novel methods. Since its inception in 2009, CPRIT has funded over US $30 million in prevention grants. While the majority of funding provided in these grants supports the delivery of cancer prevention services, many of these grants include an evaluation component that takes into account some aspect of the broad field of health services research, i.e. it access, quality, cost—generally at the community level. CPRIT’s prevention grant program uniquely brings together the fields of cancer prevention and health services research, making Texas a robust CP-HSR laboratory for the nation.
Funding Information:
Through discussion, we identified the VA system as a model for CP-HSR. Health Services Research and Development Service (HSR&D) [] is one of the four research services carried out by the Office of Research and Development at the VA and includes programs in biomedical laboratory, clinical science, health service, and rehabilitation research (Fig. ). HSR&D, which focuses on comparative effectiveness research, supports the Quality Enhancement Research Initiative and provides intramural research grant awards of a maximum of US $300,000 per year for up to 4 years. HSR&D also provides four-level career development intramural awards to maintain the HSR workforce within the VA system.
PY - 2012/5
Y1 - 2012/5
N2 - In October 2009, The University of Texas MD Anderson Cancer Center hosted a symposium, "Future Directions in Cancer Prevention and Control: Workforce Implications for Training, Practice, and Policy." This article summarizes discussions and an Internet and literature review by the symposium's Health Services Infrastructure Working Group. We agree on the need for the recognition of Cancer Prevention Health Services Research (CP-HSR) as a unified research field. With advances in cancer screening and increased emphasis on preventive services under healthcare reform, there is a growing need for investigators with both cancer prevention and HSR expertise to consider the comparative effectiveness of cancer screening methods, the cost-effectiveness of early detection technologies, and the accessibility of preventive care for individuals at risk of cancer. Defining CP-HSR as a field will provide investigators with credibility and will serve to draw more researchers to the field. Increasing funding to train individuals in CP-HSR will be important to help meet the anticipated demand for investigators with this specialized multidisciplinary expertise.
AB - In October 2009, The University of Texas MD Anderson Cancer Center hosted a symposium, "Future Directions in Cancer Prevention and Control: Workforce Implications for Training, Practice, and Policy." This article summarizes discussions and an Internet and literature review by the symposium's Health Services Infrastructure Working Group. We agree on the need for the recognition of Cancer Prevention Health Services Research (CP-HSR) as a unified research field. With advances in cancer screening and increased emphasis on preventive services under healthcare reform, there is a growing need for investigators with both cancer prevention and HSR expertise to consider the comparative effectiveness of cancer screening methods, the cost-effectiveness of early detection technologies, and the accessibility of preventive care for individuals at risk of cancer. Defining CP-HSR as a field will provide investigators with credibility and will serve to draw more researchers to the field. Increasing funding to train individuals in CP-HSR will be important to help meet the anticipated demand for investigators with this specialized multidisciplinary expertise.
KW - Cancer prevention
KW - Cancer screening
KW - Comparative effectiveness
KW - Cost-effectiveness
KW - Health service research
KW - Workforce
UR - http://www.scopus.com/inward/record.url?scp=84863720239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863720239&partnerID=8YFLogxK
U2 - 10.1007/s13187-012-0330-7
DO - 10.1007/s13187-012-0330-7
M3 - Article
C2 - 22311693
AN - SCOPUS:84863720239
SN - 0885-8195
VL - 27
SP - S149-S156
JO - Journal of Cancer Education
JF - Journal of Cancer Education
IS - SUPPL. 2
ER -